Regional growth operations of DEVA and export activities are increasing.

It has 1119 licenses in 65 countries, including USA, Switzerland, Germany and the UK.

DEVA Holding currently exports pharmaceuticals and pharmaceutical raw materials to more than 60 countries. Within the scope of DEVA international operations, depending on business models:

• Distributorship

• Out-licensing and Supply

• In-licensing

• API Export

• Contract Manufacturing

• Co-Development

• DEVA Branded Sales processes continue.